Safety and Immunogenicity of Non-live, Recombinant Subunit Herpes Zoster Vaccine Before and After Lung Transplantation
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 17 Jan 2020
Price : $35 *
At a glance
- Drugs GSK 1437173A (Primary)
- Indications Herpes zoster
- Focus Pharmacodynamics
- 24 Sep 2019 Planned End Date changed from 5 Mar 2020 to 1 Mar 2020.
- 24 Sep 2019 Status changed from recruiting to active, no longer recruiting.
- 12 Apr 2018 New trial record